After pulmonary virus infection, virus-binding B cells ectopically accumulate in the lung. However, their contribution to protective immunity against reinfecting viruses remains unknown. Here, we show the phenotypes and protective functions of virus-binding memory B cells that persist in the lung following pulmonary infection with influenza virus. A fraction of virus-binding B-cell population in the lung expressed surface markers for splenic mature memory B cells (CD73, CD80, and CD273) along with CD69 and CXCR3 that are up-regulated on lung effector/memory T cells. The lung B-cell population with memory phenotype persisted for more than 5 mo after infection, and on reinfection promptly differentiated into plasma cells that produced virus-neutralizing antibodies locally. This production of local IgG and IgA neutralizing antibody was correlated with reduced virus spread in adapted hosts. Our data demonstrates that infected lungs harbor a memory B-cell subset with distinctive phenotype and ability to provide protection against pulmonary virus reinfection.
lung memory B cells | viral immunity B -cell memory is bipartite, consisting of both long-lived plasma cells and memory B cells. Immediate protection against reinfection is mediated by long-lived plasma cells that are present in the bone marrow and secrete antibodies in an antigen-independent fashion. Recall responses are mediated by memory B cells that rapidly proliferate and differentiate in response to antigenic stimulation (1, 2) . The accessibility of memory B cells to reinfecting pathogens is, therefore, likely a significant factor in determining the effectiveness of humoral protection against reinfection. Thus, it is fundamentally important to determine the protective functions of pathogen-specific memory B cells that reside at the sites of infection after the resolution of a primary infection.
In the case of influenza virus, the initial infection and replication occur in the respiratory tract. These elicit immune responses in associated secondary lymphoid organs, e.g., mediastinal lymph nodes (MLNs), which support the initial rounds of B-cell priming that follow a pulmonary infection (3) . In addition, nonlymphoid organs, including the lungs, participate in these primary responses. Indeed, after primary infection with influenza virus, infected lungs often support the development of ectopic tertiary lymphoid structures known as induced bronchus-associated lymphoid tissue (iBALT) that contain germinal centers (GCs) and plasma cells (4) . Moreover, infected lungs harbor the precursors of virusbinding plasma cells as revealed after in vitro stimulation of lung cells (5, 6) , suggesting the existence of virus-binding memory B cells in the lungs. However, virus-binding memory B cells in the lungs have not been indentified at cellular level, thereby their phenotypic and functional characterization is still lacking.
In this study, we characterized the phenotypes and functions of class-switched, influenza-specific B cells in the lungs. We show that a fraction of class-switched, influenza-specific B cells in the lungs possess a memory phenotype, persist for a long period, and respond to virus reinfection by promoting rapid viral clearance. Our data demonstrate that local tissues are important sites for the maintenance and reactivation of protective humoral memory responses.
Results
Infection with Influenza Virus Induces Antigen-Specific Memory-Like B-Cell Population in Lung. Pulmonary infection with influenza viruses induces precursors of antigen-specific, class-switched plasma cells in the lungs (5, 6) ; however, the phenotypes of these cells have not been determined. To characterize the phenotype and persistence of influenza-specific B cells in lungs, we labeled B cells recovered from lung tissue with recombinant hemagglutinin (rHA) conjugated to PE. Non-B cells, transitional B cells, B1 cells, and plasma cells were excluded from our analyses by colabeling with 12 mAbs specific for their surface markers (SI Materials and Methods and Fig. S1 ). IgM/D + cells were also excluded from the present analysis to reduce the risk of including naïve HA-binding B cells present in the preimmune repertoire (7) . This staining procedure resulted in the clear visualization of HA-binding, class-switched B cells in mice infected with the X31 influenza virus but not with other influenza virus subtypes (Fig.  S1 ), confirming our methods' specificity and sensitivity. Among the HA-binding IgM/D − lung B cells was a CD38 + subset that could represent a memory B-cell population (8, 9) . We first traced the numbers of both CD38 + and CD38 − B cells in lung, MLN, and spleen for 160 d after a primary infection ( Fig. 1 A  and B) . The numbers of HA-binding IgM/D
−

CD38
− B cells rapidly but transiently increased in lung, MLN, and spleen. However, CD38
− B cells in MLNs persisted for a longer period than those in lungs and spleens, similar to splenic or MLN GCs following vesicular stomatitis or influenza virus infection, respectively (10, 11) .
HA-binding IgM/D − CD38 + B cells were found in the lung, MLN, and spleen, but lung CD38 + B cells required more time to reach equilibrium than that required for CD38 + B cells in other organs (Fig. 1B) . This process resembles the slower accumulation of plasma cells in the lungs after influenza virus infection (11) and may reflect a requirement for structural alteration and/ or niche formation in the infected lungs for B-cell localization.
Once generated, HA-binding IgM/D
−
CD38
+ B cells stably persisted for 160 d after infection in all organs.
Although definitive markers of murine memory B cells remain to be identified (12, 13) , CD73, CD80, and CD273 (PD-L2) are expressed at higher levels on splenic memory than on naïve B cells (14, 15 
CD138
+ cells expressing plasmablasts/plasma cell markers accumulated in the lungs, and about half of these expressed IgA (Fig. 2B ). ELISPOT analysis confirmed the prompt appearance of plasma cells in the lungs consisting of comparable frequencies of IgG-or IgA-secreting plasma cells (Fig. S4 ). These results suggest that, in response to virus reinfection, the memory-like Bcell population in lung divided and developed into plasma cells. 
CD38
+ B cells were highly purified from the lungs and spleens of the mice >2 mo after primary infection, and then transferred into scid mice together with CD4 + T cells isolated from the same donors. MLNs provided too few cells for adoptive transfer experiments and were not used. Accumulating evidence indicates that iBALT serves not only a site for initiating respiratory immune responses but also as a homing site for plasma cells (18, 19) . Therefore, we considered that preforming iBALT structure might be required for reconstitution of local, secondary Ab responses to virus infection in adoptive hosts. To generate iBALTs in recipient mice before memory B-cell transfer, recipient scid mice were subjected to intranasal CpG treatment and i.v. transfer of spleen cells. As expected, this treatment generated peribronchial B-cell clusters 10 d later ( Fig. 3 A and B) . The treated mice were inoculated with challenging viruses 1 d after transfer of purified HA-binding IgM/D − CD38 + B cells (Fig. 3C) , and then we determined virus titers in BALFs 6 d after infection. Remarkably, the mice reconstituted with the memory-like B-cell population in lung significantly reduced virus titers in BALFs, whereas those given splenic counterparts were similar to controls (Fig. 3D) . Moreover, the protective ability of lung memory-like B-cell population was not observed in recipient mice without pre-CpG treatment (Fig. 3E) .
To address whether adoptive transfer of the memory-like Bcell population in lung accelerated the Ab production in the respiratory tract, the numbers of HA-binding lung plasma cells and the levels of anti-HA Abs in BALFs were evaluated at the same time point. Adoptive transfer of lung memory-like B-cell population generated sixfold more IgG-and IgA-secreting plasma cells in the lungs compared with splenic counterparts in a manner depending on pre-CpG treatment of recipient mice (Fig. 3 F and G) . Consistent with the results in secondary challenged BALB/c mice, the frequencies of IgA-secreting plasma cells were comparable to those of IgG-secreting plasma cells. These results support the contention that the enhanced IgA response following secondary infection reflects the increased supply of IgA-secreting plasma cells from memory and not naïve B cells. In accordance with ELISPOT data, anti-HA IgG and IgA Ab titers in BALFs were elevated in the mice reconstituted with the lung B-cell population after CpG treatment but not in those given the splenic B-cell population (Fig. 3H) Although it is established that secretory IgA can provide protection more effectively than IgG in upper respiratory tracts (20, 21) , it is not known whether IgA in lower respiratory tracts contributes to protection in the presence of IgG. To estimate the contribution of IgG and IgA Abs in BALFs to virus neutralization, we first determined the titers of HA-binding IgG and IgA Abs. Consistent with comparable accumulation of IgG-and IgAsecreting plasma cells in the lungs (Figs. 2 and 3 ), BALFs in secondary challenged mice contained both HA-binding IgG and IgA Abs (Fig. 4A) . The relative contributions of IgG and IgA to virus neutralization were estimated using BALFs depleted of either IgG or IgA Abs by affinity chromatography. We observed that removal of either IgG or IgA reduced virus-neutralizing activity of BALFs by two-to threefold (Fig. 4B) , indicating partial, but not complete, reduction in activity. Moreover, removal of both IgG and IgA reduced virus-neutralizing activity to levels close to the detection limit. These data suggest that concomitant production of IgG and IgA Abs is required to achieve maximum neutralization activity. viruses, which are defective in replication but retain structure of virus particles. Reactivated lung memory B cells generated IgAsecreting plasma cells at increased frequencies of 40% among class-switched plasma cells (Fig. 5 A and B) . (Fig. 5C ). Single-cell RT-PCR analysis revealed that only 2.1% of sorted IgA − population express J H -Cα mRNA (Fig. S5) . The reactivated lung IgA − memory B cells generated both IgG-and IgA-secreting plasma cells approximately at a ratio of 3:1 (Fig. 5D) , suggesting the recruitment of IgA-secreting plasma cells from IgA − memory B cells after secondary stimulation with virus particles. Moreover, IgA production through IgA − memory B cells required the restimulation with virus particles, as rHA proteins could not elicit IgA-secreting plasma cells from IgA − memory B cells, whereas IgG-secreting plasma cells were comparably generated (Fig. 5E) . Together, these data show that secondary IgA production is enhanced by recruitment of IgA-secreting plasma cells from IgA − memory B cells in a manner dependent on virus particles.
Discussion
Here, we have demonstrated that infected lungs harbor antigenspecific, class-switched B cells expressing CD38, CD73, CD80, and CD273, which are the most reliable surrogate markers for murine memory B cells. Moreover, two lines of evidences support that they promptly differentiate into mature plasma cells upon reinfection. First, lung memory B cells started to proliferate on day 2 after reinfection, when memory B cells in MLNs and spleens were still inert ( Fig. 2A) . Second, transferred lung memory B cells were able to generate IgG and IgA-secreting plasma cells in the lungs of adopted hosts after reinfection. Together, we conclude that antigen-specific memory B cells localize and respond to antigenic challenge in the lungs following pulmonary influenza virus infection.
The most striking feature of lung memory B cells is their ability to reduce virus spread in lower respiratory tracts of recipient mice. Given that lung memory B cells provided local IgG and IgA Ab in recipient mice following virus challenge, it is conceivable that both isotypes contribute to virus neutralization in situ. This idea is supported by the fact that virus neutralization depends on both IgG and IgA Abs in vitro (Fig. 4) . Dispensability of IgA for providing protection in the lower respiratory tracts was previously suggested as vaccinated, IgA-deficient mice were found to be fully resistant to pulmonary influenza virus infection (22) . However, IgA-deficient mice might use compensatory mechanisms that lead to altered expression of other Ab isotypes (23, 24) . Given that systemic injection of anti-HA IgA mAbs was effective to prevent the initial infection in lung airways (25), we prefer the idea that both IgG and IgA Abs in lung airways contribute to virus neutralization. The mechanism underlying the ability of lung memory B cells to supply local IgG and IgA Abs remains an important question to be addressed. Lung memory B cells express CD69 and CXCR3, possible mediators of lung localization. Thus, one possibility is that transferred lung memory B cells home back to the lung, wherein they could generate IgG-and IgA-secreting plasma cells at virus replication sites. This possibility is supported by requirement for intranasal CpG treatment before memory B-cell transfer. CpG-induced inflammation would trigger the local expression of several ligands (e.g., CXCL9 and CXCL10) for chemokine and/or homing receptors expressed on lung memory B cells. However, without pre-CpG treatment, the reduction of virus spread was not observed in the mice reconstituted with lung memory B cells (Fig. 3 D-G) . The alternative possibility is that transferred lung memory B cells home to the MLNs, where they supply plasma cells in the lungs upon reinfection. Although we made tremendous efforts for in vivo tracing of transferred memory B cells, our attempts were unsuccessful due to a paucity of memory B cells.
B-cell intrinsic recognition of intact viruses is often hampered by the tissue tropisms of virus replication in nonlymphoid organs. Following pulmonary influenza virus infection, lung localization of memory B cells is one way to facilitate B cell intrinsic recognition for shaping the magnitude and quality of protective effector functions. Better understanding of the generation, maintenance, and reactivation of memory B cells in lung provides important insights for the development of vaccines for protection against influenza virus and other respiratory pathogens.
Materials and Methods
Mice and Viruses. Mice and viruses used in this study are described in SI Materials and Methods.
Cell Preparation and Flow Cytometry. Lung cells were isolated by Percoll gradient centrifugation after digestion with collagenase D and DNase I. Single-cell suspensions from lungs, MLNs, and spleens were stained with mixtures of biotinylated mAbs, followed by fluorescence-conjugated mAbs. BrdU-labeled cells were detected by using BrdU Flow kit (BD Biosciences). Stained cells were analyzed or purified using FACS Canto II or FACS Aria (BD Bioscience). Detailed methods are included in SI Materials and Methods.
Quantification of Anti-HA Abs and Plasma Cells. HA-binding Abs and plasma cells were quantified by ELISA and ELISPOT using rHA as coating antigens and anti-mouse IgG-or IgA Abs as secondary Abs. Virus-neutralization Ab titers were quantified by microneutralization assay using MDCK cells and X31 virus (100 TCID 50 ) (26) . Detailed methods are included in SI Materials and Methods.
Statistical Analyses of Data. Statistical significance was determined by an unpaired two-tailed Student t test. P < 0.05 were considered significant. and the numbers of IgG + and IgA + plasma cells were determined after boosting with inactivated viruses or rHA. In A, B, D, and E, each circle represents the result for an individual recipient mouse. *P < 0.05; **P < 0.01.
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SI Materials and Methods
Mice and Viruses. Female BALB/c and CB17-scid mice were maintained under specific pathogen-free conditions and used in experiments at the age of 7-12 wk. The influenza A viruses X31 (H3N2) and A/New Caledonia/20/99 (H1N1) were grown in a 10-d-old embryonated hen eggs and were purified through a 10-50% sucrose gradient as described (1) . BALB/c mice, anesthetized by i.p. injection with sodium pentobarbital, were inoculated intranasally with 0.1 lethal dose 50 (LD 50 ) for the primary challenge or 10 LD 50 for the secondary challenge in a volume of 20 μL. In some experiments, CB17-scid mice were injected with 15 μg of ODN-DNA bearing CpG-motifs intranasally (2) and 1 × 10 8 BALB/c splenocytes intravenously. All mice were used in accordance with the guidelines of the Institutional Animal Care and Use Committee of the National Institute of Infectious Diseases, Japan.
Cell Preparation. Single-cell suspensions were prepared from spleens and MLNs in DMEM containing 2% (vol/vol) FCS, 2 mM L-glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin, and 5 × 10 −5 M β-mercaptoethanol as described (3) . For isolation of lung cells, mice were perfused with PBS in the right ventricle to clear the lungs of blood. Lungs were minced and incubated at 37°C for 30 min in 1 mg/mL collagenase D (Roche) and 10 μg/mL DNase I (Roche) and then disrupted between the frosted ends of glass slides. After 70%/44% (vol/vol) Percoll gradient centrifugation, the cells between the 70%/44% interface were recovered.
Preparation of Recombinant HA Protein. cDNA encoding 1-529 amino acid residues of X31 HA was amplified by PCR using high fidelity DNA polymerase (KOD-Plus-Ver.2, Toyobo). During the PCR amplification, 6× His tag sequence was attached to C-terminal sequence of the truncated HA. BamH I and NotI sites were also incorporated into its N-and C-terminal sequence, respectively. Amplified cDNA was inserted into cloning site of pBacPAK8 expression vector (Clontech) and transfected into Sf21 (Spodoptera frugiperda) insect cells. Recombinant HA proteins tagged with 6× His were produced in Sf21 cells adapted to FCS-free conditions and purified from culture supernatant using TALON columns (Clontech), in accordance with the manufacture's protocol.
Abs. Anti-FcγRII/III (2.4G2) mAbs were purified in our laboratory. Recombinant HA was conjugated with PE in our laboratory. Flow Cytometry and Cell Sorting. Cells were pretreated with antiFcγRII/III mAb and then incubated with biotinylated mAbs against IgM, IgD, CD43, CD138, CD5, CD93, CD90, CD3, F4/80, CD11b, CD117, CD11c, Gr-1, and TER-119 for memory B cells and IgM, IgD, CD90, CD3, F4/80, and Gr-1 for plasma cells. This was followed by staining with anti-B220-Pacific Blue, rHA-PE, SA-Tricolor, propidium iodide (PI), and anti-CD38-APC or anti-B220-Pacific Blue, anti-CD38-FITC, rHA-PE, SA-PE-TexasRed, and PI (memory B cells). Plasma cells were stained by anti-B220-Pacific Blue, anti-IgA-FITC, rHA-PE, SA-PE-TexasRed, PI, and anti-CD138-APC. BrdU-labeled cells were detected by using BrdU Flow Kit (BD Biosciences). For sorting memory B cells, cells that were stained with biotinylated Abs were depleted using a MACS column (Miltenyi Biotech), followed by staining with fluorescence-conjugated reagents. Stained cells were analyzed or purified using FACS Canto II or FACS Aria (BD Bioscience). A total of >200,000 events were collected, and data were analyzed with FlowJo software (TreeStar).
Detection of Anti-HA Abs and Plasma Cells. For detection of anti-HA plasma cells by ELISPOT, nitrocellulose membranes were coated with 20 μg/mL rHA, and cells were incubated on the membranes for 2 h at 37°C. After the cells were washed off, the membranes were incubated with anti-mouse IgG2a-AP/anti-mouse IgA-HRP, anti-mouse IgG2b-AP/anti-mouse IgG1-HRP, or antimouse IgM-AP/anti-mouse IgG3-HRP. AP and HRP activities were visualized as described (3) . For detection of anti-HA Ab titers, ELISA was performed using anti-mouse IgG-HRP or antimouse IgA-HRP as described (1) . IgG and IgA was removed from BALFs by passage through Sepharose columns conjugated to goat anti-mouse IgG and IgA, respectively. Virus-neutralization Ab titers in BALFs were determined by microneutralization assay using MDCK cells (1) . In brief, serially diluted BALFs were incubated with X31 virus (100 TCID 50 ) for 30 min at 37°C and then added to MDCK cells together with acetyltrypsin (Sigma). After 3-d incubation, the dilution at which 50% of the cultures were protected from infection were determined and plotted as virus-neutralization Ab titers.
Histology. Lung tissues were recovered after intratracheal injection of 50% OCT compound in PBS. After freezing, sections (5 μm) were deposited on slides and fixed in ice-cold acetone. For immunohistochimistry, sections were pretreated with Image-iT FX Signal Enhancer (Invitrogen). Endogenous biotin was blocked using a streptavidin/biotin blocking kit (Vector Laboratories). Sections were then stained with anti-CD90-biotin, followed by anti-B220-AlexaFluor647, SA-AlexaFluor555, and DAPI. Stained sections were scanned under a confocal laserscanning microscope LSM 510 (Carl Zeiss).
Adoptive Cell Transfer. B cells and CD4 + T cells were purified from pooled spleens using a MACS system with biotinylated mAbs against CD3, CD90, CD4, F4/80, Gr-1, CD11b, CD43, and CD138 (B cells) and CD19, B220, IgM, IgD, F4/80, Gr-1, CD11b, and CD8 (CD4 + T cells), followed by SA-microbeads (Miltenyi Biotech). B cells (2 × 10 6 per head) from naïve mice and CD4 + T cells (1 × 10 6 per head) from infected mice were i.v. injected into CB17-scid mice with or without sorted memory B cells. On the next day, the recipient mice were intraperitoneally boosted with inactivated viruses (20 μg) or intranasally infected with X31 (5 LD 50 RT-PCR mixture (OneStep RT-PCR kit, Qiagen) was prepared to include primer pairs for β-actin and J H -Cα and dispersed at 15 μL per well. Primers used for PCR were β-actin sense 5′-AC-TATTGGCAACGAGCGGTTC, and β-actin antisense 5′-CCA-CCGATCCACACAGAGTA; J H 1 sense 5′-GTCTGGGGCGC-AGGGACCAC, J H 2 sense 5′-GGGCCAAGGCACCACTCT-CAC, J H 3 sense 5′-GGGGCCAAGGGACTCTGGTCA, J H 4 sense 5′-GGGTCAAGGAACCTCAGTCACCG, and Cα antisense 5′ CCCAGGTCACATTCATCGTGCCG. One-step RT-PCR was performed by 1 cycle of 30 min at 50°C, 1 cycle of 15 min at 95°C, 40 cycles of 10 s at 94°C, 30 s at 60°C, 60 s at 72°C. The PCR products were separated by a 1.5% agarose gel electrophoresis and the samples including DNA bands of β-actin (284 bp) and J H -Cα (155-160 bp) were judged as positive for J H -Cα, and those including only β-actin as negative. 
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